ADAM28 and precursor B-cell acute lymphoblastic leukemia: Our results have predicted several potential therapeutic targets that could be repurposed for B-ALL, and that the ADAM28 gene product could potentially predict B-ALL with 100 percent accuracy in our combined dataset.